Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura Rossi

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Frontiers in Microbiology|January 8, 2015
Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virusMohsen Navari, Fabio Fuligni, Maria A Laginestra, et al.
Biomed Research International|January 7, 2014
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemiaMaura Rossi, Fabio Fuligni, Maria Ciccone, et al.
Cancer Research|November 17, 2007
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulationPier Paolo Piccaluga, Claudio Agostinelli, Andrea Califano, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 7, 2023
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic TargetsClaudio Agostinelli, Luca Morandi, Simona Righi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 2024
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effectsVittorio Fusco, Massimo Di Maio, Anna Amela Valsecchi, et al.
Therapeutic Advances in Hematology|April 2, 2014
The evolution of clonality testing in the diagnosis and monitoring of hematological malignanciesAnna Gazzola, Claudia Mannu, Maura Rossi, et al.
Advances in Hematology|January 22, 2011
Pathobiology of hodgkin lymphomaPier Paolo Piccaluga, Claudio Agostinelli, Anna Gazzola, et al.
British Journal of Haematology|July 22, 2015
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphomaEnrica Marchi, Kelly M Zullo, Jennifer E Amengual, et al.
Clinical and Translational Medicine|April 25, 2025
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid LeukemiaManuela Mancini, Sara De Santis, Cecilia Monaldi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2019
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specifiedMaria Antonella Laginestra, Luciano Cascione, Giovanna Motta, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Frontiers in Microbiology|January 8, 2015
Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virusMohsen Navari, Fabio Fuligni, Maria A Laginestra, et al.
Biomed Research International|January 7, 2014
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemiaMaura Rossi, Fabio Fuligni, Maria Ciccone, et al.
Cancer Research|November 17, 2007
Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulationPier Paolo Piccaluga, Claudio Agostinelli, Andrea Califano, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 7, 2023
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic TargetsClaudio Agostinelli, Luca Morandi, Simona Righi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 2024
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effectsVittorio Fusco, Massimo Di Maio, Anna Amela Valsecchi, et al.
Therapeutic Advances in Hematology|April 2, 2014
The evolution of clonality testing in the diagnosis and monitoring of hematological malignanciesAnna Gazzola, Claudia Mannu, Maura Rossi, et al.
Advances in Hematology|January 22, 2011
Pathobiology of hodgkin lymphomaPier Paolo Piccaluga, Claudio Agostinelli, Anna Gazzola, et al.
British Journal of Haematology|July 22, 2015
The combination of hypomethylating agents and histone deacetylase inhibitors produce marked synergy in preclinical models of T-cell lymphomaEnrica Marchi, Kelly M Zullo, Jennifer E Amengual, et al.
Clinical and Translational Medicine|April 25, 2025
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid LeukemiaManuela Mancini, Sara De Santis, Cecilia Monaldi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 28, 2019
Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specifiedMaria Antonella Laginestra, Luciano Cascione, Giovanna Motta, et al.
Pageof 8